Washington: Researchers have established a novel gene therapy strategy which is an excellent substitute for the current expensive and uncontrollable Vascular endothelial growth factor (VEGF) gene delivery system.The discovery of the hyperbranched poly(amidoamine) (hPAMAM) nanoparticle based hypoxia regulated vascular endothelial growth factor (HRE-VEGF) gene therapy strategy, by Dr Changfa Guo, Professor Chunsheng Wang and their …
Continue reading “New economical gene therapy strategy promotes cardiac repair”